Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors

Clinical trial NCT07584954 · RECRUITING

Trial details

NCT number: NCT07584954
Sponsor: Jun Zhou
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Cancer Solid Tumor Cancer Treatment With Immunotherapy

Start date: 2024-06-18
Primary completion: 2028-06-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.